Author:
Li Sanwang,Wang Yikun,Zhang Bikui,Cai Hualin
Funder
National Natural Science Foundation of China
Natural Science Foundation of Hunan Province
Xiangya Hospital, Central South University
Subject
Cell Biology,Clinical Biochemistry,Biochemistry,General Medicine,Analytical Chemistry
Reference27 articles.
1. Analysis of novel melphalan hydrolysis products formed under isolated lung perfusion conditions using liquid chromatography/tandem mass spectrometry;Boschmans;Rapid. Commun. Mass. Spectrom.,2013
2. A phase I and pharmacokinetic study of melphalan using a 24-hour continuous infusion in patients with advanced malignancies;Pinguet;Clin. Cancer Res.,2000
3. Fifty years of melphalan use in hematopoietic stem cell transplantation;Bayraktar;Biol. Blood Marrow Transplant.,2013
4. H. Hassan, K. Verma, G. Ferri, D. Brauneis, K. Quillen, J.M. Sloan, V. Sanchorawala, C.V. Edwards, Modified High-Dose versus High-Dose Melphalan Conditioning in Older Patients Undergoing Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis, Transpl. Cell Ther. (2022). doi: 10.1016/j.jtct.2022.08.007.
5. Paperspray ionization mass spectrometry as a tool for predicting real-time optimized dosing of the chemotherapeutic drug melphalan;Zhao;J. Appl. Lab. Med.,2021